Researchers Quantify the Risk for Diabetes After Gestational Diabetes
By Elana Gotkine HealthDay Reporter
THURSDAY, May 9, 2024 -- Gestational diabetes is associated with an increased risk for subsequent diabetes, with higher risk for gestational diabetes in second pregnancy and in both first and second pregnancies, according to a study published online May 9 in JAMA Network Open.
Joseph Mussa, from McGill University in Montreal, and colleagues compared the hazards of incident diabetes among those with gestational diabetes in the first, second, and both pregnancies compared to women without gestational diabetes in a retrospective cohort study.
Data were included from 431,980 women with two singleton deliveries; 2.5, 3.7, and 1.9 percent had gestational diabetes in their first pregnancy, their second pregnancy, and both pregnancies, respectively. The researchers found that the risk for incident diabetes was increased 4.35-, 7.68-, and 15.8-fold with first pregnancy-only gestational diabetes, second pregnancy-only gestational diabetes, and gestational diabetes in both pregnancies, respectively. Compared with first pregnancy-only gestational diabetes, the hazard was increased 76 percent and 3.63-fold with second pregnancy-only gestational diabetes and gestational diabetes in both pregnancies, respectively.
"Our results provide a personalized medicine-oriented pathway to diabetes risk estimation in women," the authors write. "This should be coupled with tailored prevention programs and equitable referral pathways to reduce the burden of type 2 diabetes and its complications."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2024
Read this next
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
WEDNESDAY, April 30, 2025 -- Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2...
Sodium-Glucose Cotransporter 2 Inhibitors Increase Risk for Falls in Patients With Diabetes
WEDNESDAY, April 30, 2025 -- Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk factor for falls in people with type 2 diabetes, according to a study...
GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM
THURSDAY, April 17, 2025 -- Both glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) are associated with a reduced risk...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.